Diseases [C] » Nutritional and Metabolic Diseases [C18] » Nutrition Disorders » Overnutrition » Overweight » Obesity » Obesity, Abdominal
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Body Weight » Overweight » Obesity » Obesity, Abdominal
Description
A condition of having excess fat in the abdomen. Abdominal obesity is typically defined as waist circumferences of 40 inches or more in men and 35 inches or more in women. Abdominal obesity raises the risk of developing disorders, such as DIABETES; HYPERTENSION; and METABOLIC SYNDROME. MeSH
Hierarchy View
Phase 3 Indicated Drugs (4)
Phase 2 Indicated Drugs (8)
Phase 1 Indicated Drugs (1)
Other Experimental Indicated Drugs (43)
Organization Involved with Phase 4 Indications (12)
Organization Involved with Phase 3 Indications (8)
Organization Involved with Phase 2 Indications (12)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (36)
Agriculture and Agri-Food Canada
Bogomolets National Medical University
Clinical Research Institute HUCH Ltd
Federal University of Rio de Janeiro
Institut National de la Santé Et de la Recherche Médicale, France
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.